Transgene Biotek Board of Directors
Get the latest insights into the leadership at Transgene Biotek. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Dr. K Koteswara Rao | Chairman & Managing Director |
| Mrs. Sujana Kadiam | Director |
| Mrs. Swetha Marri | Director |
| Mr. Santosh Kumar | Director |
Transgene Biotek Share price
TRABI
4.01
0.16 (4.16%)Last updated on 4 Sep, 2025 | 15:27 IST
BUYSELL
Today's High
4.09
Today's Low
3.86
52 Week Low
3.22
52 Week High
8.79
The current prices are delayed, login to your account for live prices
LoginTransgene Biotek FAQs
The board at Transgene Biotek consists of experienced professionals, including Dr. K Koteswara Rao , Mrs. Sujana Kadiam , and others, overseeing the company’s strategic and corporate governance.
Directors at Transgene Biotek are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Dr. K Koteswara Rao is the current chairman at Transgene Biotek.
Executive directors at Transgene Biotek are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Transgene Biotek adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Transgene Biotek, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.